Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data.

Ammann EM, Kalsekar I, Yoo A, Johnston SS.

Pharmacoepidemiol Drug Saf. 2018 Jul 12. doi: 10.1002/pds.4617. [Epub ahead of print]

PMID:
30003617
2.

Prevalence and Determinants of Engagement with Obesity Care in the United States.

Stokes A, Collins JM, Grant BF, Hsiao CW, Johnston SS, Ammann EM, Berry KM, Tong C, Scamuffa RF.

Obesity (Silver Spring). 2018 May;26(5):814-818. doi: 10.1002/oby.22173. Epub 2018 Apr 6.

3.

Obesity Progression Between Young Adulthood and Midlife and Incident Diabetes: A Retrospective Cohort Study of U.S. Adults.

Stokes A, Collins JM, Grant BF, Scamuffa RF, Hsiao CW, Johnston SS, Ammann EM, Manson JE, Preston SH.

Diabetes Care. 2018 May;41(5):1025-1031. doi: 10.2337/dc17-2336. Epub 2018 Mar 5.

PMID:
29506982
4.

Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.

Ammann EM, Cuker A, Carnahan RM, Perepu US, Winiecki SK, Schweizer ML, Leonard CE, Fuller CC, Garcia C, Haskins C, Chrischilles EA.

Medicine (Baltimore). 2018 Feb;97(8):e9960. doi: 10.1097/MD.0000000000009960.

5.

Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.

Ammann EM, Schweizer ML, Robinson JG, Eschol JO, Kafa R, Girotra S, Winiecki SK, Fuller CC, Carnahan RM, Leonard CE, Haskins C, Garcia C, Chrischilles EA.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):398-404. doi: 10.1002/pds.4398. Epub 2018 Feb 15.

PMID:
29446185
6.

Chart validation of inpatient ICD-9-CM administrative diagnosis codes for ischemic stroke among IGIV users in the Sentinel Distributed Database.

Ammann EM, Leira EC, Winiecki SK, Nagaraja N, Dandapat S, Carnahan RM, Schweizer ML, Torner JC, Fuller CC, Leonard CE, Garcia C, Pimentel M, Chrischilles EA.

Medicine (Baltimore). 2017 Dec;96(52):e9440. doi: 10.1097/MD.0000000000009440.

7.

Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Ammann EM, Shanafelt TD, Larson MC, Wright KB, McDowell BD, Link BK, Chrischilles EA.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e11-e25. doi: 10.1016/j.clml.2017.07.004. Epub 2017 Jul 19.

PMID:
28802891
8.

Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length.

Ammann EM, Shanafelt TD, Wright KB, McDowell BD, Link BK, Chrischilles EA.

Leuk Lymphoma. 2018 Mar;59(3):643-649. doi: 10.1080/10428194.2017.1349905. Epub 2017 Jul 18.

PMID:
28718694
9.

Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation.

Ammann EM, Drake MT, Haraldsson B, Wallace RB, Johnson KC, Desai P, Lin EM, Link BK.

Cancer. 2017 Nov 1;123(21):4168-4177. doi: 10.1002/cncr.30858. Epub 2017 Jun 27.

PMID:
28654155
10.

Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).

Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS.

Prostaglandins Leukot Essent Fatty Acids. 2017 Jun;121:68-75. doi: 10.1016/j.plefa.2017.06.006. Epub 2017 Jun 15.

11.

A reply to Ovanesov et al.

Ammann EM, Chrischilles EA.

Am J Hematol. 2017 Apr;92(4):E45. doi: 10.1002/ajh.24645. Epub 2017 Feb 13. No abstract available.

12.

Sequential lignin depolymerization by combination of biocatalytic and formic acid/formate treatment steps.

Gasser CA, Čvančarová M, Ammann EM, Schäffer A, Shahgaldian P, Corvini PF.

Appl Microbiol Biotechnol. 2017 Mar;101(6):2575-2588. doi: 10.1007/s00253-016-8015-5. Epub 2016 Nov 30.

PMID:
27904924
13.

Arsenic Mobilization from Historically Contaminated Mining Soils in a Continuously Operated Bioreactor: Implications for Risk Assessment.

Rajpert L, Kolvenbach BA, Ammann EM, Hockmann K, Nachtegaal M, Eiche E, Schäffer A, Corvini PF, Skłodowska A, Lenz M.

Environ Sci Technol. 2016 Sep 6;50(17):9124-32. doi: 10.1021/acs.est.6b02037. Epub 2016 Aug 9.

PMID:
27454004
14.

Production of superparamagnetic nanobiocatalysts for green chemistry applications.

Gasser CA, Ammann EM, Schäffer A, Shahgaldian P, Corvini PF.

Appl Microbiol Biotechnol. 2016 Aug;100(16):7281-96. doi: 10.1007/s00253-016-7479-7. Epub 2016 Apr 23.

PMID:
27106914
15.

Enzyme Shielding in an Enzyme-thin and Soft Organosilica Layer.

Correro MR, Moridi N, Schützinger H, Sykora S, Ammann EM, Peters EH, Dudal Y, Corvini PF, Shahgaldian P.

Angew Chem Int Ed Engl. 2016 May 17;55(21):6285-9. doi: 10.1002/anie.201600590. Epub 2016 Apr 9.

PMID:
27062137
16.

Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.

Ammann EM, Haskins CB, Fillman KM, Ritter RL, Gu X, Winiecki SK, Carnahan RM, Torner JC, Fireman BH, Jones MP, Chrischilles EA.

Am J Hematol. 2016 Jun;91(6):594-605. doi: 10.1002/ajh.24358. Epub 2016 Apr 24. Review.

17.

Assessing the use of nanoimmobilized laccases to remove micropollutants from wastewater.

Arca-Ramos A, Ammann EM, Gasser CA, Nastold P, Eibes G, Feijoo G, Lema JM, Moreira MT, Corvini PF.

Environ Sci Pollut Res Int. 2016 Feb;23(4):3217-28. doi: 10.1007/s11356-015-5564-6. Epub 2015 Oct 21.

PMID:
26490891
18.

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy.

Ammann EM, Jones MP, Link BK, Carnahan RM, Winiecki SK, Torner JC, McDowell BD, Fireman BH, Chrischilles EA.

Blood. 2016 Jan 14;127(2):200-7. doi: 10.1182/blood-2015-05-647552. Epub 2015 Oct 6.

19.

Laccases to take on the challenge of emerging organic contaminants in wastewater.

Gasser CA, Ammann EM, Shahgaldian P, Corvini PF.

Appl Microbiol Biotechnol. 2014 Dec;98(24):9931-52. doi: 10.1007/s00253-014-6177-6. Epub 2014 Oct 31. Review.

PMID:
25359481
20.

Omega-3 fatty acid biomarkers and subsequent depressive symptoms.

Persons JE, Robinson JG, Ammann EM, Coryell WH, Espeland MA, Harris WS, Manson JE, Fiedorowicz JG.

Int J Geriatr Psychiatry. 2014 Jul;29(7):747-57. doi: 10.1002/gps.4058. Epub 2013 Dec 11.

21.

Advanced enzymatic elimination of phenolic contaminants in wastewater: a nano approach at field scale.

Gasser CA, Yu L, Svojitka J, Wintgens T, Ammann EM, Shahgaldian P, Corvini PF, Hommes G.

Appl Microbiol Biotechnol. 2014 Apr;98(7):3305-16. doi: 10.1007/s00253-013-5414-8. Epub 2013 Dec 5.

PMID:
24305739
22.

ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA.

Ammann EM, Pottala JV, Harris WS, Espeland MA, Wallace R, Denburg NL, Carnahan RM, Robinson JG.

Neurology. 2013 Oct 22;81(17):1484-91. doi: 10.1212/WNL.0b013e3182a9584c. Epub 2013 Sep 25.

23.

Immobilization of defined laccase combinations for enhanced oxidation of phenolic contaminants.

Ammann EM, Gasser CA, Hommes G, Corvini PF.

Appl Microbiol Biotechnol. 2014 Feb;98(3):1397-406. doi: 10.1007/s00253-013-5055-y. Epub 2013 Jun 29.

PMID:
23812279
24.

Determination of oxidoreductase activity using a high-throughput microplate respiratory measurement.

Hommes G, Gasser CA, Ammann EM, Corvini PF.

Anal Chem. 2013 Jan 2;85(1):283-91. doi: 10.1021/ac302716j. Epub 2012 Dec 11.

PMID:
23181606

Supplemental Content

Loading ...
Support Center